Research Article
The Impact of Hyperoxia on Outcome of Patients Treated with Noninvasive Respiratory Support
| | Age (years) | 68.5 ± 15.7 |
| | APACHE II | 19.1 ± 6.6 | | Highest PaO2 during the first 24 hours (mmHg) | 111.1 ± 50.0 | | Requirement for IMV, (n, %) | 56 (29.9) | | Days on IMV (days) | 21.8 ± 55.3 | | ICU stay (days) | 12.4 ± 23.6 | | Hospital stay (days) | 30.5 ± 36.4 | | Mean SaO2 during the first 24 hours (%) | 94.5 ± 2.8 | | Gender (m/f) | 88/99 | | Transferred from (n, %) | | | Emergency service | 112 (59.9) | | Other in-hospital | 75 (40.1) | | Comorbidities (n, %) | | | COPD | 54 (28.9) | | CHD | 39 (20.9) | | CHF | 39 (21.4) | | CRF | 32 (17.1) | | HT | 101 (54) | | DM | 59 (31.6) | | CLF | 13 (7) | | Malignancy | 54 (29.9) | | Dementia | 8 (4.3) | | O2 treatment modality in the first 24 hours (n, %) | | | Oxygen supply (nasal mask and HFOT) | 77 (41.2) | | NIMV | 110 (58.8) | | Outcome (n, %) | | | Died | 56 (29.9) | | Discharged | 131 (70.1) | | Hospital mortality (n, %) | 76 (40.6) |
|
|
COPD: chronic obstructive pulmonary disease, CHD: coronary heart disease, CHF: congestive heart failure, CRF: chronic renal failure, HT: hypertension, DM: diabetes mellitus, and CLF: chronic liver failure.
|
